Initial sirolimus dosage recommendations for pediatric patients with PIK3CD mutation-related immunodeficiency disease

Initial sirolimus dosage recommendations for pediatric patients with PIK3CD mutation-related immunodeficiency disease

Sirolimus is used to treat pediatric patients with PIK3CD mutation-related immunodeficiency disease. However, the initial dosages of sirolimus remain undecided. The present study aims to explore initial dosages in pediatric patients with PIK3CD mutation-related immunodeficiency disease. Pediatric pa...

Full description

Bibliographic Details
Main Authors: Xiao Chen, Jinglin Wang, Jianger Lan, Xilin Ge, Hong Xu, Yu Zhang, Zhiping Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
sirolimus
PIK3CD mutation
immunodeficiency disease
initial dosages recommendation
pediatric patients
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.919487/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.919487/full

Similar Items